Correlation among 16 biological factors [p53, p21(waf1), MIB-1 (Ki-67), p16(INK4A), cyclin D1, E-cadherin, Bcl-2, TNF-α, NF-κB, TGF-β, MMP-7, COX-2, EGFR, HER2/neu, ER, and HIF-1α] and clinical outcomes following curative chemoradiation therapy in 10 pati

Shibata-Kobayashi S, Yamashita H, Okuma K, Shiraishi K, Igaki H, Ohtomo K, Nakagawa K.

Oncol Lett. 2013 Mar;5(3):903-910. Epub 2013 Jan 11. PMID: 23426606 [PubMed]

Dose verification of volumetric modulated arc therapy (VMAT) by use of in-treatment linac parameters.

Haga A, Sakumi A, Okano Y, Itoh S, Saotome N, Kida S, Igaki H, Shiraishi K, Yamashita H, Ohtomo K, Nakagawa K.

Radiol Phys Technol. 2013 Jul;6(2):335-42. doi: 10.1007/s12194-013-0205-6. Epub 2013 Mar 12. PMID: 23479401 [PubMed – in process]

Verification of planning target volume settings in volumetric modulated arc therapy for stereotactic body radiation therapy by using in-treatment 4-dimensional cone beam computed tomography.

Takahashi W, Yamashita H, Kida S, Masutani Y, Sakumi A, Ohtomo K, Nakagawa K, Haga A.

Int J Radiat Oncol Biol Phys. 2013 Jul 1;86(3):426-31. doi: 10.1016/j.ijrobp.2013.02.019. Epub 2013 Apr 5. PMID: 23562767 [PubMed – indexed for MEDLINE]